CLASS III Drug recall · Reported 20 Apr 2022 · FDA Enforcement Report

Cyanocobalamin Injection, USP, 1,000 mcg per mL recalled

Aurobindo Pharma USA is recalling Cyanocobalamin Injection, USP, 1,000 mcg per mL, For IM or SC Use Only Vial, distributed nationwide in the US. The recall was initiated on 5 Apr 2022 and the FDA has classified it as Class III.

Check your package

Lot, batch or date codesLots: CCC210004, Exp 09/2022; CCC210005, CCC210006, CCC210007, Exp 11/2022; CCC210010, CCC210011, Exp 04/2023.
NDC55150-364
UPC0355150364015, 0355150364107
Quantity recalled433,809 vials

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0766-2022
FDA event ID
89941
Recalling firm
Aurobindo Pharma USA, East Windsor, NJ
Manufacturer
AuroMedics Pharma LLC
Classification
Class III
Status
Terminated
Recall initiated
5 Apr 2022
FDA classified
12 Apr 2022
Reported
20 Apr 2022
Type
Voluntary: Firm initiated
Customers notified by
N/A
Reason category
Potency & Assay

Timeline

5 Apr 2022Recall initiated by company
12 Apr 2022Classified by FDA+7 days
20 Apr 2022Published in enforcement report+8 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Subpotent Drug: Out of Specification results for Assay

Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.

Product as listed by the FDA

Cyanocobalamin Injection, USP, 1,000 mcg per mL, For IM or SC Use Only, 1 mL Vial, Rx Only, Manufactured in India, for Auromedics Pharma LLC, NDC 55150-364-01.

Where it was distributed

Nationwide in the USA.

Nationwide

Questions about this recall

Why was it recalled?

Subpotent Drug: Out of Specification results for Assay

Which lots are affected?

Lots: CCC210004, Exp 09/2022; CCC210005, CCC210006, CCC210007, Exp 11/2022; CCC210010, CCC210011, Exp 04/2023.

Where was it sold?

Nationwide in the USA.

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class III mean?

Class III recalls are for products unlikely to cause any adverse health consequence, usually labelling or quality issues.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Aurobindo Pharma USA

All 59

Other Cyanocobalamin recalls

All 23